Highlights and Quick Summary
- Research and Development Expense of Revenue for the quarter ending September 30, 2023 was 316.76% (a -62.6% decrease compared to previous quarter)
- Year-over-year quarterly Research and Development Expense of Revenue decreased by -73.99%
- Annual Research and Development Expense of Revenue for 2022 was 732.6% (a 49.1% increase from previous year)
- Annual Research and Development Expense of Revenue for 2021 was 491.36% (a 58.53% increase from previous year)
- Annual Research and Development Expense of Revenue for 2020 was 309.94% (a 14.77% increase from previous year)
- Twelve month Research and Development Expense of Revenue ending September 30, 2023 was 763.23% (a 10.82% increase compared to previous quarter)
- Twelve month trailing Research and Development Expense of Revenue increased by 4.18% year-over-year
Trailing Research and Development Expense of Revenue for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| 763.23% | 688.7% | 732.5% | 732.6% |
Visit stockrow.com/ARAV
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Research and Development Expense of Revenue of ARAVIVE, INC
Most recent Research and Development Expense of Revenueof ARAV including historical data for past 10 years.Interactive Chart of Research and Development Expense of Revenue of ARAVIVE, INC
ARAVIVE, INC Research and Development Expense of Revenue for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 316.76% | 846.94% | 1067.4% | – | – |
| 2022 | 1217.98% | 376.67% | 1072.14% | 1190.66% | 732.6% |
| 2021 | 1237.97% | 470.27% | 214.3% | 2298.44% | 491.36% |
| 2020 | 114.99% | 0.0% | 0.0% | 0.0% | 309.94% |
| 2019 | 0.0% | 0.0% | 119.09% | 167.63% | 270.06% |
| 2018 | 0.0% | 0.0% | 0.0% | 0.0% | 625.46% |
| 2017 | 0.0% | 0.0% | 0.0% | 0.0% | 236.53% |
| 2016 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2015 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2014 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2013 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2012 | – | – | – | – | 0.0% |
Business Profile of ARAVIVE, INC
Sector: Healthcare
Industry: Biotechnology